Co-Authors
This is a "connection" page, showing publications co-authored by Daniel T. Ginat and Nicole A. Cipriani.
Connection Strength
5.006
-
High-Grade Conventional Osteosarcoma of the Mandible Associated With P53 Germline Mutation. J Craniofac Surg. 2018 May; 29(3):738-740.
Score: 0.631
-
Cervical Chondrocutaneous Branchial Remnants. Head Neck Pathol. 2018 Jun; 12(2):244-246.
Score: 0.596
-
Laryngotracheal Involvement in Systemic Light Chain Amyloidosis. Head Neck Pathol. 2018 Mar; 12(1):127-130.
Score: 0.594
-
Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib. Int J Surg Pathol. 2017 Oct; 25(7):613-618.
Score: 0.590
-
Oral Cavity Clear Cell Odontogenic Carcinoma. Head Neck Pathol. 2016 Jun; 10(2):217-20.
Score: 0.514
-
Langerhans Cell Histiocytosis of the Temporal Bone. Head Neck Pathol. 2016 Jun; 10(2):209-12.
Score: 0.512
-
Imaging features and surgical management of giant parathyroid adenoma with autoinfarction. J Clin Imaging Sci. 2024; 14:9.
Score: 0.238
-
Differentiating low and high grade mucoepidermoid carcinoma of the salivary glands using CT radiomics. Gland Surg. 2021 May; 10(5):1646-1654.
Score: 0.194
-
Histiocytic Necrotizing Lymphadenitis Involving the Neck: Radiology-Pathology Correlation. Head Neck Pathol. 2019 Dec; 13(4):648-651.
Score: 0.159
-
Educational Impact of Trainee-Facilitated Head and Neck Radiology-Pathology Correlation Conferences. Head Neck Pathol. 2019 Jun; 13(2):177-181.
Score: 0.158
-
Adenoid Cystic Carcinoma of the Oral Cavity: Radiology-Pathology Correlation. Head Neck Pathol. 2018 Dec; 12(4):562-566.
Score: 0.151
-
Disseminated Malignant Rhabdoid Tumor of the Head and Neck. Head Neck Pathol. 2017 Jun; 11(2):224-227.
Score: 0.141
-
Desmoid-Type Fibromatosis of the Tongue. Head Neck Pathol. 2016 Dec; 10(4):527-529.
Score: 0.137
-
Dedifferentiated Chondrosarcoma of the Larynx. Head Neck Pathol. 2016 Sep; 10(3):345-8.
Score: 0.134
-
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
Score: 0.060
-
Multimodality management of sinonasal teratocarcinosarcoma in a 76-year-old Alaska Native female during the COVID-19 pandemic. Clin Case Rep. 2022 Mar; 10(3):e05635.
Score: 0.052
-
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022 Jan 03; 22(1):17.
Score: 0.051
-
Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience. Oral Oncol. 2021 11; 122:105566.
Score: 0.050
-
Pituitary Adenoma Deposit in the Nasolabial Region Following Sublabial Transsphenoidal Surgery in the Setting of Nelson Syndrome. J Craniofac Surg. 2020 Jan/Feb; 31(1):e68-e69.
Score: 0.044